The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oncology Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global Oncology Radiopharmaceutical market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Oncology Radiopharmaceutical market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oncology Radiopharmaceutical market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oncology Radiopharmaceutical market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oncology Radiopharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oncology Radiopharmaceutical market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Radiopharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Radiopharmaceutical market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical lmaging, Inc. and NanoMab, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Oncology Radiopharmaceutical market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Drugs
Intravenous Drugs
Other
Market segment by Application
Hospitals and Clinics
Pharmaceutical Company
Research Center
Other
Major players covered
Novartis
Chimeric Therapeutics Limited
Fusion Pharma
Lantheus Medical lmaging, Inc.
NanoMab
NuView Life Sciences.
PentixaPharm GmbHPrecirix
RadioMedix
RayzeBio
Telix Pharmaceuticals Limited
Theragnostics Ltd
Vect-Horus
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology Radiopharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oncology Radiopharmaceutical, with price, sales, revenue and global market share of Oncology Radiopharmaceutical from 2018 to 2023.
Chapter 3, the Oncology Radiopharmaceutical competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Radiopharmaceutical breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oncology Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oncology Radiopharmaceutical.
Chapter 14 and 15, to describe Oncology Radiopharmaceutical sales channel, distributors, customers, research findings and conclusion.
The global Oncology Radiopharmaceutical market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Oncology Radiopharmaceutical market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oncology Radiopharmaceutical market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oncology Radiopharmaceutical market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oncology Radiopharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oncology Radiopharmaceutical market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Radiopharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Radiopharmaceutical market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical lmaging, Inc. and NanoMab, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Oncology Radiopharmaceutical market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Drugs
Intravenous Drugs
Other
Market segment by Application
Hospitals and Clinics
Pharmaceutical Company
Research Center
Other
Major players covered
Novartis
Chimeric Therapeutics Limited
Fusion Pharma
Lantheus Medical lmaging, Inc.
NanoMab
NuView Life Sciences.
PentixaPharm GmbHPrecirix
RadioMedix
RayzeBio
Telix Pharmaceuticals Limited
Theragnostics Ltd
Vect-Horus
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology Radiopharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oncology Radiopharmaceutical, with price, sales, revenue and global market share of Oncology Radiopharmaceutical from 2018 to 2023.
Chapter 3, the Oncology Radiopharmaceutical competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Radiopharmaceutical breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oncology Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oncology Radiopharmaceutical.
Chapter 14 and 15, to describe Oncology Radiopharmaceutical sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Oncology Radiopharmaceutical
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oncology Radiopharmaceutical Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral Drugs
1.3.3 Intravenous Drugs
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Oncology Radiopharmaceutical Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Clinics
1.4.3 Pharmaceutical Company
1.4.4 Research Center
1.4.5 Other
1.5 Global Oncology Radiopharmaceutical Market Size & Forecast
1.5.1 Global Oncology Radiopharmaceutical Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oncology Radiopharmaceutical Sales Quantity (2018-2029)
1.5.3 Global Oncology Radiopharmaceutical Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Oncology Radiopharmaceutical Product and Services
2.1.4 Novartis Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Chimeric Therapeutics Limited
2.2.1 Chimeric Therapeutics Limited Details
2.2.2 Chimeric Therapeutics Limited Major Business
2.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product and Services
2.2.4 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Chimeric Therapeutics Limited Recent Developments/Updates
2.3 Fusion Pharma
2.3.1 Fusion Pharma Details
2.3.2 Fusion Pharma Major Business
2.3.3 Fusion Pharma Oncology Radiopharmaceutical Product and Services
2.3.4 Fusion Pharma Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Fusion Pharma Recent Developments/Updates
2.4 Lantheus Medical lmaging, Inc.
2.4.1 Lantheus Medical lmaging, Inc. Details
2.4.2 Lantheus Medical lmaging, Inc. Major Business
2.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product and Services
2.4.4 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lantheus Medical lmaging, Inc. Recent Developments/Updates
2.5 NanoMab
2.5.1 NanoMab Details
2.5.2 NanoMab Major Business
2.5.3 NanoMab Oncology Radiopharmaceutical Product and Services
2.5.4 NanoMab Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 NanoMab Recent Developments/Updates
2.6 NuView Life Sciences.
2.6.1 NuView Life Sciences. Details
2.6.2 NuView Life Sciences. Major Business
2.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Product and Services
2.6.4 NuView Life Sciences. Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 NuView Life Sciences. Recent Developments/Updates
2.7 PentixaPharm GmbHPrecirix
2.7.1 PentixaPharm GmbHPrecirix Details
2.7.2 PentixaPharm GmbHPrecirix Major Business
2.7.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product and Services
2.7.4 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 PentixaPharm GmbHPrecirix Recent Developments/Updates
2.8 RadioMedix
2.8.1 RadioMedix Details
2.8.2 RadioMedix Major Business
2.8.3 RadioMedix Oncology Radiopharmaceutical Product and Services
2.8.4 RadioMedix Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 RadioMedix Recent Developments/Updates
2.9 RayzeBio
2.9.1 RayzeBio Details
2.9.2 RayzeBio Major Business
2.9.3 RayzeBio Oncology Radiopharmaceutical Product and Services
2.9.4 RayzeBio Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 RayzeBio Recent Developments/Updates
2.10 Telix Pharmaceuticals Limited
2.10.1 Telix Pharmaceuticals Limited Details
2.10.2 Telix Pharmaceuticals Limited Major Business
2.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product and Services
2.10.4 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Telix Pharmaceuticals Limited Recent Developments/Updates
2.11 Theragnostics Ltd
2.11.1 Theragnostics Ltd Details
2.11.2 Theragnostics Ltd Major Business
2.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Product and Services
2.11.4 Theragnostics Ltd Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Theragnostics Ltd Recent Developments/Updates
2.12 Vect-Horus
2.12.1 Vect-Horus Details
2.12.2 Vect-Horus Major Business
2.12.3 Vect-Horus Oncology Radiopharmaceutical Product and Services
2.12.4 Vect-Horus Oncology Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Vect-Horus Recent Developments/Updates
3 Competitive Environment: Oncology Radiopharmaceutical by Manufacturer
3.1 Global Oncology Radiopharmaceutical Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oncology Radiopharmaceutical Revenue by Manufacturer (2018-2023)
3.3 Global Oncology Radiopharmaceutical Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oncology Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oncology Radiopharmaceutical Manufacturer Market Share in 2022
3.4.2 Top 6 Oncology Radiopharmaceutical Manufacturer Market Share in 2022
3.5 Oncology Radiopharmaceutical Market: Overall Company Footprint Analysis
3.5.1 Oncology Radiopharmaceutical Market: Region Footprint
3.5.2 Oncology Radiopharmaceutical Market: Company Product Type Footprint
3.5.3 Oncology Radiopharmaceutical Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oncology Radiopharmaceutical Market Size by Region
4.1.1 Global Oncology Radiopharmaceutical Sales Quantity by Region (2018-2029)
4.1.2 Global Oncology Radiopharmaceutical Consumption Value by Region (2018-2029)
4.1.3 Global Oncology Radiopharmaceutical Average Price by Region (2018-2029)
4.2 North America Oncology Radiopharmaceutical Consumption Value (2018-2029)
4.3 Europe Oncology Radiopharmaceutical Consumption Value (2018-2029)
4.4 Asia-Pacific Oncology Radiopharmaceutical Consumption Value (2018-2029)
4.5 South America Oncology Radiopharmaceutical Consumption Value (2018-2029)
4.6 Middle East and Africa Oncology Radiopharmaceutical Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
5.2 Global Oncology Radiopharmaceutical Consumption Value by Type (2018-2029)
5.3 Global Oncology Radiopharmaceutical Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
6.2 Global Oncology Radiopharmaceutical Consumption Value by Application (2018-2029)
6.3 Global Oncology Radiopharmaceutical Average Price by Application (2018-2029)
7 North America
7.1 North America Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
7.2 North America Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
7.3 North America Oncology Radiopharmaceutical Market Size by Country
7.3.1 North America Oncology Radiopharmaceutical Sales Quantity by Country (2018-2029)
7.3.2 North America Oncology Radiopharmaceutical Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
8.2 Europe Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
8.3 Europe Oncology Radiopharmaceutical Market Size by Country
8.3.1 Europe Oncology Radiopharmaceutical Sales Quantity by Country (2018-2029)
8.3.2 Europe Oncology Radiopharmaceutical Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oncology Radiopharmaceutical Market Size by Region
9.3.1 Asia-Pacific Oncology Radiopharmaceutical Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oncology Radiopharmaceutical Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
10.2 South America Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
10.3 South America Oncology Radiopharmaceutical Market Size by Country
10.3.1 South America Oncology Radiopharmaceutical Sales Quantity by Country (2018-2029)
10.3.2 South America Oncology Radiopharmaceutical Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oncology Radiopharmaceutical Market Size by Country
11.3.1 Middle East & Africa Oncology Radiopharmaceutical Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oncology Radiopharmaceutical Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Oncology Radiopharmaceutical Market Drivers
12.2 Oncology Radiopharmaceutical Market Restraints
12.3 Oncology Radiopharmaceutical Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Oncology Radiopharmaceutical and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oncology Radiopharmaceutical
13.3 Oncology Radiopharmaceutical Production Process
13.4 Oncology Radiopharmaceutical Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oncology Radiopharmaceutical Typical Distributors
14.3 Oncology Radiopharmaceutical Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
